Universe Pharmaceuticals (UPC) Construction in Progress (2021 - 2024)

Universe Pharmaceuticals (UPC) has 4 years of Construction in Progress data on file, last reported at $9.2 million in Q1 2024.

• For the quarter ending Q1 2024, Construction in Progress fell 4.5% year-over-year to $9.2 million; the trailing twelve-month figure through Mar 2024 stood at $9.2 million (down 4.5% YoY), and the FY2023 full-year result was $9.1 million, down 2.5% from the prior year.
• Construction in Progress rose to $9.2 million in Q1 2024, from $9.1 million in the prior quarter.
• In the past five years, Construction in Progress ranged from a high of $10.7 million in Q3 2021 to a low of $9.1 million in Q3 2023.
• A 4-year average of $9.7 million and a median of $9.5 million in 2022 frame the typical range for Construction in Progress.
• Across the five-year window, Construction in Progress dropped 12.94% in 2022 and dropped 2.5% in 2023, its largest moves.
• Tracing UPC's Construction in Progress over 4 years: stood at $10.7 million in 2021, then retreated by 12.94% to $9.3 million in 2022, then decreased by 2.5% to $9.1 million in 2023, then grew by 1.46% to $9.2 million in 2024.
• Business Quant data shows UPC's Construction in Progress at $9.2 million in Q1 2024, $9.1 million in Q3 2023, and $9.7 million in Q1 2023.